Skip to main content

Oregon State Flag An official website of the State of Oregon »

Oregon.gov Homepage

COVID-19 Training for Vaccine Providers

All Pfizer and Moderna monovalent mRNA vaccine has been de-authorized by the FDA.

It is now an administration error to give any monovalent Pfizer or Moderna COVID-19 vaccine.

The terms “Primary Series” and “Booster” are no longer being applied to Moderna and Pfizer immunizations. Instead, recipients are either “up to date” or “not up to date”. Recipients age 6 and older are now “up to date” if they have had one dose of bivalent mRNA vaccine.

The changes are more complicated for younger kids; please see the CDC Interim Clinical Considerations for COVID-19 Vaccine.

“Additional doses” of vaccine may be given to some recipients who are “up to date” if they are:

  • Moderately or severely immunocompromised
  • Age 65 or older

Most doses of Moderna for ages 6 months through 5 years are now the blue cap, gray label vaccine (0.25mL) rather than the pink cap, yellow label vaccine (0.2mL) in the 2-dose vial which was previously authorized as the bivalent Moderna product for this age group. The pink cap, yellow label vaccine in the 2-dose vial remains authorized for specific, limited situations.

Moderna and Pfizer now each have just one EUA fact sheet.
ProvidersRecipients and Caregivers
Pfizer:Provider EUARecipient and Caregiver EUA
Moderna:Provider EUARecipient and Caregiver EUA

The Novavax immunization recommendations are not changed by the FDA’s recent update.

For specifics about who is eligible for what vaccines and schedule specifics, please see:


A summary presentation of the recent changes was delivered at OIP office hours.





Useful Links

Questions about enrolling as a COVID-19 vaccination provider: Vaccine.ProviderEnroll@dhsoha.state.or.us

COVID-19 information, enrollment information, and sample forms for providers: OHA COVID-19 Information for Providers webpage. 

COVID-19 ALERT IIS

Type of vaccine providers Required ALERT IIS Trainings
Recommended ALERT IIS Training
COVID-19 Only providers Standard User Training
Inventory Training
Super User Training *
Written guide:COVID-specific Inventory Management Guide
Written guide:COVID-19 Vaccine Ordering Process in ALERT IIS
VFC Providers also receiving COVID-19 Standard User Training
Inventory Training
Super User Training*
Written guide:COVID-specific Inventory Management Guide
Tip Sheet: How to Transfer Vaccines
Tip Sheet: Interpreting the Inventory Options in Modify Quantity
Written guide: COVID-19 Vaccine Ordering Process in ALERT IIS
*Prerequisite: Standard User access or proof of completed Standard User training is required before taking Super User Training. The Super User role is used by organizations who are approved to receive state-supplied vaccine in addition to COVID-19 vaccine. The Super User role keeps vaccine shipping information current, can submit immunization reports through file transfer, and can create new ALERT IIS user access.

COVID-19 Vaccine Storage & Handling

Type of vaccine
(Take training
for all vaccines
being administered)
Required Trainings & Materials
(Two Clinical Staff at Each Location)
Recommended Trainings
& Materials
All Vaccines

CDC Video: Intramuscular (IM) injections video
Reference: COVID-19 Vaccine Management Guide English Spanish
Review: Up to Date Including Boosters
CDC ModuleCOVID 19 Vaccine Best Practices
CDC Module: *CDC Vaccine Storage and Handling
Chart: Schedule for people without moderate/severe immunocompromise
Chart: Schedule for people with moderate/severe immunocompromise
CDC Resource: Library of tipsheets on IM injections for all age groups
Novavax 
Primary Series
12 years and older

Review: Novavax EUA Fact Sheet for Healthcare Providers Administering Vaccine
Review: Novavax EUA Fact Sheet for Recipients and Caregivers: English    Other Languages

All Pfizer
CDC ModulePfizer Training
Infographic: Pfizer products
Infosheet: Dry Ice Safety
S&H Checklist: Checklist for Storage and Handling Preparation
VideosTroubleshooting issues with your Pfizer thermal shipper
Chart: Vaccine Dosage Chart
CDC: Pfizer Webpage
Bivalent Pfizer Vaccines
PfiGrayCapBiBooster.png
PfiBiBoosterLabel.png
Do-Not-Dilute Bivalent
Original and Omicron BA.4/BA.5
12 years and older
(Gray Cap Bivalent)
Review: Pfizer Fact Sheet for Healthcare Providers
Review: Pfizer Fact Sheet for Recipients and Caregivers (Other language updates pending)
English Spanish
Chinese Korean
Tagalog Ukrainian
Vietnamese

Pediatric Bivalent
for ages 5 - 11
(Orange Cap Bivalent)

Video: Administering an IM Injections to Children
ReviewPfizer Fact Sheet for Healthcare Providers
Review: Pfizer Fact Sheet for Recipients and Caregivers (Other language updates pending)
English Spanish
Arabic Chinese – traditional
Chinese – simplified Chuukese
Hmong Korean
Marshallese Portuguese
Russian Somali
Tagalog Ukrainian
Vietnamese
CDC Standing Order: Standing Order for Administering Vaccine
S&H Summary: Storage and Handling Summary
S&H Labels: Storage and Handling Labels
BUD Labels
:  Beyond Use Date Labels
Summary: Preparation and Administration Summary
Tipsheet: Make Shots Less Stressful for Children
 
Maroon Cap Pfizer Bivalent
Primary Series, dose 3
6 months - 4 years 

ReviewPfizer Fact Sheet for Healthcare Providers
Review: Pfizer Fact Sheet for Recipients and Caregivers (Other language updates pending)

English Spanish
Farsi Chinese, simplified
Chinese, traditional Korean
Chuukese Hmong
Marshallese Portuguese
Russian Somali
Vietnamese
Video: Administering an IM Injections to Children

S&H Summary: Storage and Handling Summary
S&H Labels: Storage and Handling Labels
BUD Labels: Beyond Use Date Labels
Summary: Preparation and Administration Summary
Tipsheet: Make Shots Less Stressful for Children
Technique VideoComfort and restraining techniques for injections of younger children

All Moderna

Infographic: Moderna products

CDC ModuleModerna Training
CDC: Moderna Webpage

Bivalent Moderna Vaccines
ModBlueCapGrayBorderBiBooster.png
Moderna
Bivalent Original Omicron BA.4/BA.5
half dose ages 6 months - 5 years (most doses) and 6-11 years; full dose age 12 and older
(Blue cap, gray border)
VideoModerna Storage and Handling
ReviewModerna Fact Sheet for Healthcare Providers
Review: Moderna Fact Sheet for Recipients and Caregivers (Other languages update pending):
English Spanish
Arabic Chinese – traditional
Chinese – simplified Chuukese
Hmong Korean
Marshallese Portuguese
Russian Somali
Tagalog Ukrainian
Vietnamese
S&H Summary: Storage and Handling Summary
S&H Labels: Storage and Handling Labels
BUD Labels: Beyond Use Date Labels
Summary: Preparation and Administration Summary 

Moderna Bivalent

Pink cap, yellow border
Some doses 6 months - 5 years
only authorized in limited situations

VideoModerna Storage and Handling
ReviewModerna Fact Sheet for Healthcare Providers
Review: Moderna Fact Sheet for Recipients and Caregivers (Other languages update pending)

English Spanish
Arabic Farsi
Chinese, simplified Chinese, traditional
Chuukese Hmong
Korean Marshallese
Portuguese Russian
Somali Vietnamese

S&H Summary: Storage and Handling Summary
S&H Labels: Storage and Handling Labels
BUD Labels: Beyond Use Date Labels
Summary: Preparation and Administration Summary
Tipsheet: Make Shots Less Stressful for Children
Technique VideoComfort and restraining techniques for injections of younger children

Johnson & Johnson
CDC Module: Johnson & Johnson Training
Review: Johnson & Johnson EUA Fact Sheet for Healthcare Providers Administering Vaccine
Review: Johnson & Johnson EUA Fact Sheet for Recipients and Caregivers
Review: J&J Storage and Handling Overview and Resources
CDC Module: *CDC Vaccine Administration
CDC Module: *CDC Vaccine Storage and Handling
CDC Module: COVID 19 Vaccine Best Practices
S&H Summary: Storage and Handling Summary

* Dentists who have completed the OHSU vaccine training course and current VFC/VAP providers are not required to complete this training.
Novavax EUA Fact Sheet for Recipients and Caregivers Translations
English Arabic
Chuukese / foosun Chuuk
Chinese - Simplified
Chinese - Traditional
Hmong /Lus Hmoob
Korean Marshallese / Kajin Majol Russian
Somali / Af Soomaali Spanish / Español Vietnamese / Tiễng Việt

Want more information?

Check out these additional trainings and materials:

CDC Vaccine Storage and Handling
Vaccine Administration
VAERS Reporting

The Vaccine Adverse Events Reporting System (VAERS) is the U.S. frontline vaccine safety monitoring system, and providers play an important role in identifying and reporting potential adverse events to VAERS.

VAERS Fact Sheet
English Arabic
Chuukese / foosun Chuuk
Hmong /Lus Hmoob Korean Russian
Somali / Af Soomaali Spanish / Español Vietnamese / Tiễng Việt

Communicating with Patients about Vaccines